DOCSLIB.ORG

FGF19/SOCE/Nfatc2 Signaling Circuit Facilitates the Self

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
FGF19/SOCE/Nfatc2 Signaling Circuit Facilitates the Self 1 FGF19/SOCE/NFATc2 signaling circuit facilitates the self- 2 renewal of liver cancer stem cells 3 4 Jingchun Wang 1†, Huakan Zhao2†*, Lu Zheng3†, Yu Zhou2, Lei Wu2, Yanquan Xu1, Xiao 5 Zhang1, Guifang Yan2, Halei Sheng1, Rong Xin1, Lu Jiang1, Juan Lei2, Jiangang Zhang1, Yu 6 Chen2, Jin Peng1, Qian Chen1, Shuai Yang1, Kun Yu1, Dingshan Li1, Qichao Xie4*, 7 Yongsheng Li1,2* 8 9 1Clinical Medicine Research Center, Xinqiao Hospital, Army Medical University, 10 Chongqing 400037, China. 11 2Department of Medical Oncology, Chongqing University Cancer Hospital, Chongqing 12 400030, China. 13 3Department of Hepatobiliary Surgery, Xinqiao Hospital, Army Medical University, 14 Chongqing 400037, China. 15 4Department of Oncology, The Third Affiliated Hospital, Chongqing Medical University, 16 Chongqing 401120, China 17 18 †These authors contributed equal to this work. 19 *Correspondence ([email protected]) (H.Z.), ([email protected]) (Q.X.), 20 ([email protected]) (Y.L.). 21 22 Running title: FGF19-NFATc2 signaling promotes self-renewal of LCSCs. 23 Keywords: FGF19; Self-renewal; SOCE; NFATc2, LCSCs 24 1 25 Abstract 26 Background & Aims: Liver cancer stem cells (LCSCs) mediate therapeutic resistance and 27 correlate with poor outcomes in patients with hepatocellular carcinoma (HCC). Fibroblast 28 growth factor (FGF)-19 is a crucial oncogenic driver gene in HCC and correlates with poor 29 prognosis. However, whether FGF19 signaling regulates the self-renewal of LCSCs is 30 unknown. 31 Methods: LCSCs were enriched by serum-free suspension. Self-renewal of LCSCs were 32 characterized by sphere formation assay, clonogenicity assay, sorafenib resistance assay and 33 tumorigenic potential assays. Ca2+ image was employed to determine the intracellular 34 concentration of Ca2+. Gain- and loss-of function studies were applied to explore the role of 35 FGF19 signaling in the self-renewal of LCSCs. 36 Results: FGF19 was up-regulated in LCSCs, and positively correlated with certain self- 37 renewal related genes in HCC. Silencing FGF19 suppressed self-renewal of LCSCs, whereas 38 overexpressing FGF19 facilitated CSCs-like properties via activation of FGF receptor 39 (FGFR)-4 in none-LCSCs. Mechanistically, FGF19/FGFR4 signaling stimulated store- 40 operated Ca2+ entry (SOCE) through both the PLCγ and ERK1/2 pathways. Subsequently, 41 SOCE-calcineurin signaling promoted the activation and translocation of nuclear factors of 42 activated T cells (NFAT)-c2, which transcriptionally activated the expression of stemness- 43 related genes (e.g., NANOG, OCT4 and SOX2), as well as FGF19. Furthermore, blockade of 44 FGF19/FGFR4-NFATc2 signaling observably suppressed the self-renewal of LCSCs. 45 Conclusions: FGF19/FGFR4 axis promotes the self-renewal of LCSCs via activating 46 SOCE/NFATc2 pathway; in turn, NFATc2 transcriptionally activates FGF19 expression. 47 Targeting this signaling circuit represents a potential strategy for improving the therapeutic 48 efficacy of HCC. 49 2 50 Graphical Abstract 51 52 The pivotal molecules and pathways orchestrating the self-renewal of LCSCs remain elusive, 53 Wang et al. demonstrate that FGF19/SOCE/NFATc2 signaling circuit promotes the self- 54 renewal of LCSCs, implicating its potential as a therapeutic target for HCC therapy. 3 55 Introduction 56 Hepatocellular carcinoma (HCC), the third lethal cancer worldwide, is characterized by a 57 high rate of recurrence and therapy-resistance [1, 2]. Compelling evidence have 58 demonstrated that small heterogeneous population of liver cancer stem cells (LCSCs) with 59 self-renewal properties are critical for the progression and therapy-resistance of HCC [2, 3]. 60 Self-renewal is one of the most important properties employed by the CSCs to sustain the 61 proliferating capacity [4, 5]. Understanding the mechanisms underlying the self-renewal of 62 LCSCs will provide potential strategy to overcome the recurrence and therapy-resistance of 63 HCC. 64 Fibroblast growth factors (FGF) signaling can promote self-renewing proliferation and 65 inhibit cellular senescence in many tissues and organs [6, 7]. As a member of the hormone- 66 like FGF family, FGF19 shows high binding affinity with FGF receptor (FGFR)-4, which is 67 predominantly expressed in liver [8, 9]. Growing evidence indicates aberrant FGF19-FGFR4 68 signaling axis is a key driver in the development of HCC [8, 10, 11]. Our earlier study and 69 others indicated that FGF19 regulates a variety of functions of hepatocytes, such as bile acid 70 synthesis, proliferation, epithelial-mesenchymal transition (EMT) and apoptosis-resistance 71 in a FGFR4-dependent manner [12-15]. In addition, previous study demonstrated that 72 expressions of FGF19 positively correlated with undifferentiated state of human embryonic 73 stem cells (ESCs) [16]. However, whether FGF19 signaling is related to self-renewal 74 characteristics of LCSCs is unknown. 75 Calcium (Ca2+)-mediated signaling pathways are involved in various cellular biological 76 processes including proliferation, apoptosis, metastasis and self-renewal [17]. Store-operated 77 Ca2+ entry (SOCE), triggered by depletion of endoplasmic reticulum (ER) Ca2+, is the major 78 route of Ca2+ influx for non-excitable cells including HCC cells [17, 18]. Stromal interaction 79 molecule (STIM)-1, as an ER Ca2+ sensor, is a key mediator of SOCE activation [19, 20]. 80 We previously reported that STIM1-mediated SOCE orchestrates HCC tumorigenesis under 81 hypoxic conditions [21], whereas how SOCE is mobilized in LCSCs and regulates the HCC 82 self-renewal remain vague. Herein, we sought to assess the effect of FGF19/FGFR4 signaling 4 83 on STIM1-mediated SOCE and the self-renewal of LCSCs in vitro and in vivo. 84 Results 85 FGF19 is up-regulated in LCSCs and correlates with self-renewal related genes in HCC. 86 We firstly enriched LCSCs of Huh-7, RFP/PLC/5 and MHCC97H cells via serum-free 87 suspension [22]. After cultured for 2 weeks, Huh-7 and RFP/PLC/5 cells formed compact 88 round multicellular aggregates, while MHCC97H cells formed branching spheroids (Figure 89 S1A). The high self-renewal capacity of spheroids cells was confirmed by sphere formation 90 assay, clonogenicity assay, sorafenib resistance assay and tumorigenic potential assay (Figure 91 S1B-E). Furthermore, comparing with the parental cells, spheroids exhibited increased 92 mRNA levels of several stem cell markers, e.g., pluripotency transcription factor Nanog, 93 octamer-binding protein 4 (Oct-4), SRY-box transcription factor 2 (Sox2), CD133, c-Myc 94 and aldehyde dehydrogenase1 (ALDH1), but showed decreased mature hepatocyte markers, 95 such as albumin (ALB) and glucose-6-phosphatase (G6P) (Figure S1F). These results 96 demonstrate that the in vitro enriched LCSC populations of Huh-7, RFP/PLC/5 and 97 MHCC97H cells were successfully established. 98 Interestingly, compared with corresponding non-CSCs (NCSCs), both FGF19 expression and 99 secretion remarkably up-regulated in LCSCs (Figure 1A-C). Immunohistochemistry (IHC) 100 analysis revealed high levels of FGF19 in xenograft tumors derived from CSCs compared 101 with tumors from corresponding NCSCs (Figure 1D). During the differentiation of LCSCs, 102 we observed a gradual decrease of FGF19 expression accompanied with the decrease of 103 endogenous Nanog and the increase of ALB (Figure 1E). Next, IHC analysis of human HCC 104 samples showed that FGF19 expression was positively correlated with expressions of Nanog 105 and Oct-4, but negatively correlated with expressions of ALB (Figure 1F). These data 106 indicate that FGF19 is highly expressed in LCSCs, and correlates with stemness-related 107 genes in HCC. 108 Knockdown of FGF19 attenuates self-renewal features of LCSCs. 5 109 To investigate the role of FGF19 on self-renewal of LCSCs, we knocked-down FGF19 via 110 lentiviral introducing shRNA in the CSCs of Huh-7 and RFP/PLC/5 (Figure 2A-B). We 111 found that stemness-associated genes including NANOG, OCT4 and SOX2 were significantly 112 down-regulated, whereas mature hepatocyte markers, such as ALB and G6P were markedly 113 up-regulated, when compared with control (Figure 2A-B). Consistently, FGF19 silencing 114 significantly reduced the sphere and clone formation ability, as well as the sorafenib 115 resistance of LCSCs (Figure 2C-E). Moreover, the growth of xenograft tumors generated 116 from FGF19-deficient LCSCs was attenuated compared with control LCSCs (Figure 2F). 117 These results indicate that FGF19 is required for self-renewal in LCSCs. 118 FGF19 facilitates cancer stem cell-like properties in liver NCSCs. 119 To further validate the role of FGF19 in maintaining the stemness of HCC cells, we 120 overexpressed FGF19 in the NCSCs of Huh-7 and RFP/PLC/5 by lentiviral vector. Ectopic 121 expression of FGF19 upregulated stemness-associated genes (e.g., NANOG, OCT4 and 122 SOX2), while reduced ALB and G6P levels (Figure 3A-B). Over-expression of FGF19 123 significantly promoted clone and sphere formation, as well as the resistance to sorafenib 124 (Figure 3C-E). Furthermore, compared with the control group, FGF19 overexpression 125 significantly enhanced the tumorigenic ability of NCSCs (Figure 3F). Our previous studies 126 have shown that FGF19 promotes EMT and facilitates a survival response to ER stress via 127 FGFR4 in HCC cells [12, 13]. To determine the possible involvement of FGFR4 in FGF19- 128 mediated self-renewal of LCSCs, we generated genomic FGFR4 knockout Huh-7 and 129 RFP/PLC/5 cells by CRISPR-Cas9 system (Figure S2A-B). FGFR4 deficiency dramatically 130 suppressed self-renew properties trigged by FGF19 in NCSCs (Figure 3A-F). Moreover, 131 BLU9931, a specific FGFR4 inhibitor, also attenuated the FGF19-induced self-renewal 132 properties in NCSCs of Huh-7 and RFP/PLC/5 (Figure S3A-E). These results demonstrate 133 that FGF19 facilitates self-renewal properties via FGFR4 activation in HCC cells. 134 Enhanced SOCE is involved in FGF19-promoted self-renewal of HCC cells. 135 Recent evidence indicated that Ca2+ oscillation frequency positively correlated with the self- 6 136 renewal potential in Hep-12 cells [23], we next wondered whether SOCE-mediated Ca2+ 137 signal was involved in FGF19-mediated self-renewal activity.
Load more

Recommended publications
  • FGF19 Protects Hepatocellular Carcinoma Cells Against Endoplasmic Reticulum Stress Via Activation of FGFR4-Gsk3β-Nrf2 Signaling
    Author Manuscript Published OnlineFirst on September 26, 2017; DOI: 10.1158/0008-5472.CAN-17-2039 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. FGF19 protects hepatocellular carcinoma cells against endoplasmic reticulum stress via activation of FGFR4-GSK3β-Nrf2 signaling Yong Teng1,2#*, Huakan Zhao3,4#, Lixia Gao1, Wenfa Zhang3, Austin Y Shull5, Chloe Shay6 1. Department of Oral Biology, Augusta University, Augusta, GA, USA 2. Georgia Cancer Center, Augusta University, Augusta, GA, USA 3. School of Life Sciences, Chongqing University, Chongqing, China 4. Institute of Cancer, Xinqiao Hospital, Third Military Medical University, Chongqing, China 5. Department of Biology, Presbyterian College, Clinton, SC, USA 6. Emory Children’s Center, Emory University, Atlanta, GA, USA # These authors contributed equally to this work Running Title: Role of FGF19 in ER stress Key Words: FGF19, FGFR4, Nrf2, HCC, ER stress, anticancer Abbreviations list: AARE: amino-acid-response element; ANOVA: analysis of variance; ARE: antioxidant response elements; ATF4: activating transcription factor 4; ChIP-qPCR: chromatin immunoprecipitation quantitative-PCR; CV: cyclic voltammetry; DMSO: dimethyl sulfoxide; EMT: epithelial-mesenchymal transition; ER: endoplasmic reticulum; FGF19: fibroblast growth factor 19; FGFR4: FGF receptor 4; GSK3β: glycogen synthase kinase •− 3β; HCC: hepatocellular carcinoma; Nrf2: nuclear factor E2-related factor 2; O2 : superoxide; PBS: phosphate-buffered saline; ROS: reactive free
    [Show full text]
  • ARTICLES Fibroblast Growth Factors 1, 2, 17, and 19 Are The
    0031-3998/07/6103-0267 PEDIATRIC RESEARCH Vol. 61, No. 3, 2007 Copyright © 2007 International Pediatric Research Foundation, Inc. Printed in U.S.A. ARTICLES Fibroblast Growth Factors 1, 2, 17, and 19 Are the Predominant FGF Ligands Expressed in Human Fetal Growth Plate Cartilage PAVEL KREJCI, DEBORAH KRAKOW, PERTCHOUI B. MEKIKIAN, AND WILLIAM R. WILCOX Medical Genetics Institute [P.K., D.K., P.B.M., W.R.W.], Cedars-Sinai Medical Center, Los Angeles, California 90048; Department of Obstetrics and Gynecology [D.K.] and Department of Pediatrics [W.R.W.], UCLA School of Medicine, Los Angeles, California 90095 ABSTRACT: Fibroblast growth factors (FGF) regulate bone growth, (G380R) or TD (K650E) mutations (4–6). When expressed at but their expression in human cartilage is unclear. Here, we deter- physiologic levels, FGFR3-G380R required, like its wild-type mined the expression of entire FGF family in human fetal growth counterpart, ligand for activation (7). Similarly, in vitro cul- plate cartilage. Using reverse transcriptase PCR, the transcripts for tivated human TD chondrocytes as well as chondrocytes FGF1, 2, 5, 8–14, 16–19, and 21 were found. However, only FGF1, isolated from Fgfr3-K644M mice had an identical time course 2, 17, and 19 were detectable at the protein level. By immunohisto- of Fgfr3 activation compared with wild-type chondrocytes and chemistry, FGF17 and 19 were uniformly expressed within the showed no receptor activation in the absence of ligand (8,9). growth plate. In contrast, FGF1 was found only in proliferating and hypertrophic chondrocytes whereas FGF2 localized predominantly to Despite the importance of the FGF ligand for activation of the resting and proliferating cartilage.
    [Show full text]
  • Up-Regulation of Fibroblast Growth Factor 19 and Its Receptor Associates with Progression from Fatty Liver to Hepatocellular Carcinoma
    www.impactjournals.com/oncotarget/ Oncotarget, Vol. 7, No. 32 Research Paper Up-regulation of fibroblast growth factor 19 and its receptor associates with progression from fatty liver to hepatocellular carcinoma Yan Li1,*, Weizhong Zhang2,*, Anne Doughtie1, Guozhen Cui3, Xuanyi Li1, Harshul Pandit1, Yingbin Yang1, Suping Li1, Robert Martin1 1Division of Surgical Oncology, Department of Surgery, School of Medicine, University of Louisville, Louisville, KY, 40202, USA 2Department of Hand Surgery, China-Japan Union Hospital, Jilin University, Changchun, Jilin, 130022, China 3Department of Hepatology, Cancer Center, The First Hospital of Jilin University, Changchun, 130021, China *These authors contributed equally to this work Correspondence to: Yan Li, email: [email protected] Robert Martin, email: [email protected] Keywords: hepatocellular carcinoma, FGF19, FGFR4, cancer stem cell Received: February 08, 2016 Accepted: June 12, 2016 Published: July 21, 2016 ABSTRACT Background: Human fibroblast growth factor 19 (FGF19), its receptor (FGFR4) and EpCAM play an important role in cell proliferation, differentiation, motility, and overexpression have been linked to hepatocellular carcinoma (HCC). The aim of this study was to evaluate the FGF19 signals responsible for the progression of HCC arising from fatty liver. Results: FGF19 level was significantly increased in the HCC patients’ serum compared to non-HCC controls. The IHC results demonstrated significant increases of protein expressions of FGF19, FGFR4 and EpCAM in specimens with fatty liver, NASH, cirrhosis, and HCC compared to healthy liver tissue. There was a significant positive correlation between the protein expressions (FGF19, FGFR4, and EpCAM) and histopathologic changes from FL to HCC. Furthermore, FGF19 was positively correlated with FGFR4 and with EpCAM.
    [Show full text]
  • FGF21 Acts As a Negative Regulator of Bile Acid Synthesis
    237 2 Journal of M M Chen, C Hale et al. FGF21 negative regulator of bile 237:2 139–152 Endocrinology acid metabolism RESEARCH FGF21 acts as a negative regulator of bile acid synthesis Michelle M Chen*, Clarence Hale*, Shanaka Stanislaus, Jing Xu and Murielle M Véniant Department of Cardiometabolic Disorders, Amgen Inc., Thousand Oaks, California, USA Correspondence should be addressed to M M Véniant: [email protected] *(M M Chen and C Hale contributed equally to this work) Abstract Fibroblast growth factor 21 (FGF21) is a potent regulator of glucose and lipid Key Words homeostasis in vivo; its most closely related subfamily member, FGF19, is known to be a f FGF21 critical negative regulator of bile acid synthesis. To delineate whether FGF21 also plays a f Fc-fusion protein functional role in bile acid metabolism, we evaluated the effects of short- and long-term f β-klotho binding exposure to native FGF21 and long-acting FGF21 analogs on hepatic signal transduction, f bile acid gene expression and enterohepatic bile acid levels in primary hepatocytes and in rodent and monkey models. FGF21 acutely induced ERK phosphorylation and inhibited Cyp7A1 mRNA expression in primary hepatocytes and in different rodent models, although less potently than recombinant human FGF19. Long-term administration of FGF21 in mice fed a standard chow diet resulted in a 50–60% decrease in bile acid levels in the liver and small intestines and consequently a 60% reduction of bile acid pool size. In parallel, colonic and fecal bile acid was decreased, whereas fecal cholesterol and fatty acid excretions were elevated.
    [Show full text]
  • FGF Signaling Network in the Gastrointestinal Tract (Review)
    163-168 1/6/06 16:12 Page 163 INTERNATIONAL JOURNAL OF ONCOLOGY 29: 163-168, 2006 163 FGF signaling network in the gastrointestinal tract (Review) MASUKO KATOH1 and MASARU KATOH2 1M&M Medical BioInformatics, Hongo 113-0033; 2Genetics and Cell Biology Section, National Cancer Center Research Institute, Tokyo 104-0045, Japan Received March 29, 2006; Accepted May 2, 2006 Abstract. Fibroblast growth factor (FGF) signals are trans- Contents duced through FGF receptors (FGFRs) and FRS2/FRS3- SHP2 (PTPN11)-GRB2 docking protein complex to SOS- 1. Introduction RAS-RAF-MAPKK-MAPK signaling cascade and GAB1/ 2. FGF family GAB2-PI3K-PDK-AKT/aPKC signaling cascade. The RAS~ 3. Regulation of FGF signaling by WNT MAPK signaling cascade is implicated in cell growth and 4. FGF signaling network in the stomach differentiation, the PI3K~AKT signaling cascade in cell 5. FGF signaling network in the colon survival and cell fate determination, and the PI3K~aPKC 6. Clinical application of FGF signaling cascade in cell polarity control. FGF18, FGF20 and 7. Clinical application of FGF signaling inhibitors SPRY4 are potent targets of the canonical WNT signaling 8. Perspectives pathway in the gastrointestinal tract. SPRY4 is the FGF signaling inhibitor functioning as negative feedback apparatus for the WNT/FGF-dependent epithelial proliferation. 1. Introduction Recombinant FGF7 and FGF20 proteins are applicable for treatment of chemotherapy/radiation-induced mucosal injury, Fibroblast growth factor (FGF) family proteins play key roles while recombinant FGF2 protein and FGF4 expression vector in growth and survival of stem cells during embryogenesis, are applicable for therapeutic angiogenesis. Helicobacter tissues regeneration, and carcinogenesis (1-4).
    [Show full text]
  • Targeting FXR and FGF19 to Treat Metabolic Diseases—Lessons
    1720 Diabetes Volume 67, September 2018 Targeting FXR and FGF19 to Treat Metabolic Diseases— Lessons Learned From Bariatric Surgery Nadejda Bozadjieva,1 Kristy M. Heppner,2 and Randy J. Seeley1 Diabetes 2018;67:1720–1728 | https://doi.org/10.2337/dbi17-0007 Bariatric surgery procedures, such as Roux-en-Y gastric diabetes (T2D) (1). Clinical data demonstrate that patients bypass (RYGB) and vertical sleeve gastrectomy (VSG), who have undergone RYGB or VSG experience increased are the most effective interventions available for sus- satiety and major glycemic improvements prior to significant tained weight loss and improved glucose metabolism. weight loss, suggesting that metabolic changes as result Bariatric surgery alters the enterohepatic bile acid cir- of these surgeries are essential to the weight loss and glycemic culation, resulting in increased plasma bile levels as well benefits (2). Therefore, it is important to identify the medi- as altered bile acid composition. While it remains unclear ators that play a role in promoting the benefits of these why both VSG and RYGB can alter bile acids, it is possible surgeries with the goal of improving current surgical that these changes are important mediators of the approaches and developing less invasive therapies that effects of surgery. Moreover, a molecular target of bile harness these effects. acid synthesis, the bile acid–activated transcription fac- The effectiveness of bariatric surgery to reduce body tor FXR, is essential for the positive effects of VSG on weight and improve glucose metabolism highlights the weight loss and glycemic control. This Perspective examines the relationship and sequence of events be- important role the gastrointestinal tract plays in regulat- tween altered bile acid levels and composition, FXR ing a wide range of metabolic processes.
    [Show full text]
  • Factor Nfatc2 Responses in Mice Lacking the Transcription Impaired
    Impaired Mast Cell-Driven Immune Responses in Mice Lacking the Transcription Factor NFATc2 This information is current as Marc Becker, Valeska Heib, Matthias Klein, Fatma Doener, of September 24, 2021. Tobias Bopp, Christian Taube, Markus Radsak, Hansjörg Schild, Edgar Schmitt and Michael Stassen J Immunol 2009; 182:6136-6142; ; doi: 10.4049/jimmunol.0802878 http://www.jimmunol.org/content/182/10/6136 Downloaded from References This article cites 33 articles, 13 of which you can access for free at: http://www.jimmunol.org/content/182/10/6136.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 24, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Impaired Mast Cell-Driven Immune Responses in Mice Lacking the Transcription Factor NFATc21 Marc Becker,* Valeska Heib,† Matthias Klein,* Fatma Doener,* Tobias Bopp,* Christian Taube,‡ Markus Radsak,‡ Hansjo¨rg Schild,* Edgar Schmitt,* and Michael Stassen2* The three calcium-dependent factors NFATc1, c2, and c3 are expressed in cells of the immune system and play pivotal roles in modulating cellular activation.
    [Show full text]
  • Differential Specificity of Endocrine FGF19 and FGF21 to FGFR1 and FGFR4 in Complex with KLB
    Differential Specificity of Endocrine FGF19 and FGF21 to FGFR1 and FGFR4 in Complex with KLB Chaofeng Yang1, Chengliu Jin1, Xiaokun Li3, Fen Wang1, Wallace L. McKeehan1,2, Yongde Luo1,2* 1 Center for Cancer and Stem Cell Biology, Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, Texas, United States of America, 2 IBT Proteomics and Nanotechnology Laboratory, Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, Texas, United States of America, 3 School of Pharmacy, Wenzhou Medical College, Wenzhou, China Abstract Background: Recent studies suggest that betaKlotho (KLB) and endocrine FGF19 and FGF21 redirect FGFR signaling to regulation of metabolic homeostasis and suppression of obesity and diabetes. However, the identity of the predominant metabolic tissue in which a major FGFR-KLB resides that critically mediates the differential actions and metabolism effects of FGF19 and FGF21 remain unclear. Methodology/Principal Findings: We determined the receptor and tissue specificity of FGF21 in comparison to FGF19 by using direct, sensitive and quantitative binding kinetics, and downstream signal transduction and expression of early response gene upon administration of FGF19 and FGF21 in mice. We found that FGF21 binds FGFR1 with much higher affinity than FGFR4 in presence of KLB; while FGF19 binds both FGFR1 and FGFR4 in presence of KLB with comparable affinity. The interaction of FGF21 with FGFR4-KLB is very weak even at high concentration and could be negligible at physiological concentration. Both FGF19 and FGF21 but not FGF1 exhibit binding affinity to KLB. The binding of FGF1 is dependent on where FGFRs are present.
    [Show full text]
  • Activation of the Vitamin D Receptor Selectively Interferes With
    Laboratory Investigation (2016) 96, 784–790 © 2016 USCAP, Inc All rights reserved 0023-6837/16 Activation of the vitamin D receptor selectively interferes with calcineurin-mediated inflammation: a clinical evaluation in the abdominal aortic aneurysm Arend Jan Nieuwland1, Vivianne BC Kokje1, Olivier H Koning2, Jaap F Hamming1, Karoly Szuhai3, Frans HJ Claas4 and Jan HN Lindeman1 In vitro and in vivo studies attribute potent immune regulatory properties to the vitamin D receptor (VDR). Yet, it is unclear to what extend these observations translate to the clinical context of (vascular) inflammation. This clinical study evaluates the potential of a VDR agonist to quench vascular inflammation. Patients scheduled for open abdominal aneurysm repair received paricalcitol 1 μg daily during 2–4 weeks before repair. Results were compared with matched controls. Evaluation in a parallel group showed that AAA patients are vitamin D insufficient (median plasma vitamin D: 43 (30–62 (IQR)) nmol/l). Aneurysm wall samples were collected during surgery, and the inflammatory footprint was studied. The brief paricalcitol intervention resulted in a selective 73% reduction in CD4+ T-helper cell content (Po0.024 ) and a parallel 35% reduction in T-cell (CD3+) content (Po0.032). On the mRNA level, paricalcitol reduced expression of T-cell-associated cytokines IL-2, 4, and 10 (Po0.019). No effect was found on other inflammatory mediators. On the protease level, selective effects were found for cathepsin K (Po0.036) and L (Po0.005). Collectively, these effects converge at the level of calcineurin activity. An effect of the VDR agonist on calcineurin activity was confirmed in a mixed lymphocyte reaction.
    [Show full text]
  • Lowered Dietary Phosphorus Affects Intestinal and Renal Gene
    Just et al. BMC Genomics (2018) 19:207 https://doi.org/10.1186/s12864-018-4584-2 RESEARCH ARTICLE Open Access Lowered dietary phosphorus affects intestinal and renal gene expression to maintain mineral homeostasis with immunomodulatory implications in weaned piglets Franziska Just1, Michael Oster1, Kirsten Büsing2, Luisa Borgelt2, Eduard Murani1, Siriluck Ponsuksili1, Petra Wolf2 and Klaus Wimmers1,2* Abstract Background: In monogastric animals, phosphorus (P) homeostasis is maintained by regulating intestinal absorption, bone mobilization, and renal excretion. Since P is a non-renewable resource, a shortage is imminent due to widespread over-usage in the farming and animal husbandry industries. As a consequence, P efficiency should be improved in pig production. We sought to characterize the transcriptional response in re−/absorbing and excreting tissues in pigs to diets varying in calcium: phosphorus ratios. Weaned piglets were assigned to one of three groups fed diets varying in digestible P content for a period of five weeks. Gene expression profiles were analyzed in jejunum, colon, and kidney. Results: Transcriptome analysis revealed that reduced dietary P intake affects gene expression in jejunum and kidney, but not in colon. The regulation of mineral homeostasis was reflected via altered mRNA abundances of CYP24A1, CYP27A1, TRPM6, SPP1, and VDR in jejunum and kidney. Moreover, lowered abundances of transcripts associated with the classical complement system pathway were observed in the jejunum. In kidney, shifted transcripts were involved in phospholipase C, calcium signaling, and NFAT signaling, which may have immunomodulatory implications. Conclusions: Our results revealed local transcriptional consequences of variable P intake in intestinal and renal tissues. The adaptive responses are the result of organismal efforts to maintain systemic mineral homeostasis while modulating immune features at local tissue sites.
    [Show full text]
  • A Bioinformatics Model of Human Diseases on the Basis Of
    SUPPLEMENTARY MATERIALS A Bioinformatics Model of Human Diseases on the basis of Differentially Expressed Genes (of Domestic versus Wild Animals) That Are Orthologs of Human Genes Associated with Reproductive-Potential Changes Vasiliev1,2 G, Chadaeva2 I, Rasskazov2 D, Ponomarenko2 P, Sharypova2 E, Drachkova2 I, Bogomolov2 A, Savinkova2 L, Ponomarenko2,* M, Kolchanov2 N, Osadchuk2 A, Oshchepkov2 D, Osadchuk2 L 1 Novosibirsk State University, Novosibirsk 630090, Russia; 2 Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences, Novosibirsk 630090, Russia; * Correspondence: [email protected]. Tel.: +7 (383) 363-4963 ext. 1311 (M.P.) Supplementary data on effects of the human gene underexpression or overexpression under this study on the reproductive potential Table S1. Effects of underexpression or overexpression of the human genes under this study on the reproductive potential according to our estimates [1-5]. ↓ ↑ Human Deficit ( ) Excess ( ) # Gene NSNP Effect on reproductive potential [Reference] ♂♀ NSNP Effect on reproductive potential [Reference] ♂♀ 1 increased risks of preeclampsia as one of the most challenging 1 ACKR1 ← increased risk of atherosclerosis and other coronary artery disease [9] ← [3] problems of modern obstetrics [8] 1 within a model of human diseases using Adcyap1-knockout mice, 3 in a model of human health using transgenic mice overexpressing 2 ADCYAP1 ← → [4] decreased fertility [10] [4] Adcyap1 within only pancreatic β-cells, ameliorated diabetes [11] 2 within a model of human diseases
    [Show full text]
  • Markers of Liver Regeneration—The Role of Growth Factors and Cytokines
    Hoffmann et al. BMC Surgery (2020) 20:31 https://doi.org/10.1186/s12893-019-0664-8 RESEARCH ARTICLE Open Access Markers of liver regeneration—the role of growth factors and cytokines: a systematic review Katrin Hoffmann*†, Alexander Johannes Nagel†, Kazukata Tanabe, Juri Fuchs, Karolin Dehlke, Omid Ghamarnejad, Anastasia Lemekhova and Arianeb Mehrabi Abstract Background: Post-hepatectomy liver failure contributes significantly to postoperative mortality after liver resection. The prediction of the individual risk for liver failure is challenging. This review aimed to provide an overview of cytokine and growth factor triggered signaling pathways involved in liver regeneration after resection. Methods: MEDLINE and Cochrane databases were searched without language restrictions for articles from the time of inception of the databases till March 2019. All studies with comparative data on the effect of cytokines and growth factors on liver regeneration in animals and humans were included. Results: Overall 3.353 articles comprising 40 studies involving 1.498 patients and 101 animal studies were identified and met the inclusion criteria. All included trials on humans were retrospective cohort/observational studies. There was substantial heterogeneity across all included studies with respect to the analyzed cytokines and growth factors and the described endpoints. Conclusion: High-level evidence on serial measurements of growth factors and cytokines in blood samples used to predict liver regeneration after resection is still lacking. To address
    [Show full text]